Regulatory T Cells for More Targeted Immunosuppressive Therapies

There has been a prolific amount of research dedicated to the T-regulatory cells (Tregs) and their role in achieving immune homeostasis. Here, the authors briefly discuss the known biology, utilization, and potential of Tregs, for current trials and future immunotherapy. Most current trials of Treg therapies include either ex  vivo expanded Tregs transferred into the peripheral blood of patients with diseases of immunologic origin or interleukin 2 injected to stimulate Tregs directly. Ongoing trials designed to measure the clinical efficacy and safety profile of these novel therapeutic approaches have resulted in largel y favorable outcomes in a variety of autoimmune and alloimmune diseases. (Source: Clinics in Laboratory Medicine)

from #Head and Neck by Sfakianakis via simeraentaxei on Inoreader https://ift.tt/2Sa6CM3